Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 266 clinical trials
Treat-and-extend Using Aflibercept for Type 3 Neovascularization

-used, effective anti-vascular endothelial growth factor treatment regimen for neovascular AMD, regardless of subtypes of AMD. The purpose of the present study is to investigate the 18-month treatment

  • 0 views
  • 04 Mar, 2021
Botox Instead of Strabismus Surgery (BISS)

The purpose of the study is to evaluate if strabismus can be successfully treated requiring less surgical interventions with a Botox-based treatment regimen compared to a purely surgery based

  • 51 views
  • 24 Jan, 2021
  • 9 locations
Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children

, group A and group B randomly based on treatment regimen offered. Group A: Amoxicillin AMO + Clarithromycin CLA + Proton pump inhibitor PPI) Group B: Amoxicillin AMO+ Metronidazole MET+ Proton

  • 0 views
  • 28 Jan, 2021
  • 1 location
Re-treatment of HCV Following DAA Failure

standard DAA-based treatment regimen will be invited to participate. We propose to re-treat them with the anti-HCV drug combination which appears to be the most suited to his/her clinical profile, based on

velpatasvir
ribavirin
cirrhosis
daclatasvir
hcv genotype
  • 19 views
  • 23 Jan, 2021
  • 2 locations
Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis

. Patients will be treated following a one month on, one month off treatment regimen for 12 months. The primary objective is to evaluate the safety and tolerability of Aztrenam lysine in these

  • 7 views
  • 15 Feb, 2021
  • 6 locations
Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy

transplantation, an antiemetic treatment regimen in respect to efficacy and safety in patients with multiple myeloma. To the best of our knowledge effects of Aprepitant on Melphalan induced CINV have

melphalan
high dose chemotherapy
remission
dexamethasone
  • 5 views
  • 07 Nov, 2020
Treating Severe Brain-injured Patients With Apomorphine

follow-up. Shortly before and after the treatment regimen, the subjects will receive a multimodal assessment battery including neuroimaging exams. Primary outcome will be determined as behavioral

  • 7 views
  • 23 Jan, 2021
  • 2 locations
FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer

FOLFOX4 plus Avastin has been suggested as firstline regimen for advanced colorectal cancer by NCCN, a new angiogenesis inhibitor, known as Endostar(Recombinant Human Endostatin), prolonged the overall survival, time to progression and improved response rate in metastatic lung cancer in a large phase III clinical trial in china, so we …

avastin
measurable disease
lung cancer
  • 12 views
  • 07 Nov, 2020
  • 1 location
Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer

This is a single arm, open-label Phase II clinical trial to Evaluate the Efficacy and Safety of the Combination of Nab-paclitaxel and Gemcitabine in Treating Patients with metastatic pancreatic cancer.

  • 0 views
  • 22 Jan, 2021
  • 1 location
Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with the chronic use of NRTIs. Changing the HAART regimen in patients with a sustained virological response from a PI plus NRTI to a …

haart
lipodystrophy
raltegravir
  • 34 views
  • 08 Nov, 2020
  • 1 location